Intrinsic value of Plus Therapeutics, Inc. (PSTV)
Live fair value data for Plus Therapeutics, Inc. (PSTV) is currently unavailable. Please check again shortly.
Current Price: $373.00
Valuation: Overvalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Plus Therapeutics, Inc. (PSTV) undervalued or overvalued?
Based on the current model output, Plus Therapeutics, Inc. appears to be overvalued with a downside of 14.00%.
Fair value vs market price — Plus Therapeutics, Inc. (PSTV)
Unlock premium access to view the live fair value comparison against current market price for PSTV.
Frequently Asked Questions - PSTV
How is PSTV intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for PSTV.
Is PSTV undervalued or overvalued right now?
PSTV is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for PSTV: open their intrinsic value pages.